Ocular Therapeutix, Inc.

Ocular Therapeutix is a biopharmaceutical company committed to improving vision by developing and commercializing innovative therapies for retinal diseases and other eye conditions. Their primary focus is on delivering sustained-release drug therapies using their proprietary ELUTYX technology, a bioresorbable hydrogel matrix that encapsulates a drug to provide sustained and localized delivery. This technology has been implemented in their FDA-approved product DEXTENZA, a corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis, as well as in their other product candidates, including AXPAXLI, a treatment for wet age-related macular degeneration, and PAXTRAVA, a treatment for open-angle glaucoma or ocular hypertension.

The company is dedicated to research and innovation, with a robust pipeline of product candidates designed to address critical unmet needs in eye care. They are actively pursuing clinical trials and partnerships to expand their portfolio and deliver effective and safe ophthalmic products that enhance the overall patient and physician experience. Ocular Therapeutix is driven by a strong commitment to diversity, equity, and inclusion, reflected in their company culture and values. They strive to provide opportunities for professional growth and advancement for all employees, creating a collaborative and supportive work environment.

Ocular Therapeutix offers a flexible work environment with three flex holidays per year for cultural, religious, or personal reasons, in addition to standard vacation, sick, holiday, and bereavement leave. The company also provides opportunities for career development and advancement, and its unique and eclectic culture promotes a flexible workplace.

Ocular Therapeutix offers a comprehensive benefits package to their employees, including medical, dental, and vision coverage, a 401(k) plan with a generous 50% match, an employee stock purchase program, a minimum of 12 official holidays and 3 floating holidays per year, paid time off for vacation, sick leave, holidays, and bereavement, supplemental life insurance for employees, spouse, and children, short-term and long-term disability coverage, an employee assistance program, flexible spending accounts for medical and dependent care expenses, and access to a health and wellness program.

Ocular Therapeutix is a biopharmaceutical company dedicated to improving vision through the development and commercialization of innovative therapies for retinal diseases and other eye conditions. Their commitment to enhancing patient lives drives their research, focusing on creating effective and safe treatments that address unmet needs in eye care. Their proprietary ELUTYX technology enables the creation of sustained-release drug therapies, minimizing the need for frequent injections and offering a more convenient and comfortable treatment experience.

Ocular Therapeutix promotes a collaborative and innovative culture that values individual commitment and fosters professional growth. They strive to create an entrepreneurial and fast-paced environment that attracts self-starters, ambitious individuals, and talented professionals who are eager to contribute to the company's mission of enhancing patient care in ophthalmology.

Ocular Therapeutix is committed to fostering a diverse, equitable, and inclusive workplace. They believe that embracing different perspectives, experiences, and backgrounds strengthens their ability to innovate and achieve their mission of improving vision. They strive to create a culture of mutual respect and teamwork, where all employees feel welcomed, connected, and valued. This commitment is reflected in their hiring practices, training programs, leadership development initiatives, and employee benefits, including flexible holidays to accommodate diverse cultural and religious needs.